Skip to content
injectcompass
The Comparison· Supplies

Needle sizes for peptide injection

Gauge and length conventions for subcutaneous injection as described in the published technique literature. Comparison of ancillary insulin-syringe products. Not medical advice.

ByThe InjectCompass Editorial TeamUpdatedApril 21, 202612 min read

Affiliate disclosureInjectCompass may earn a commission on medical-supply links (syringes, sharps containers, travel coolers). We do not affiliate-link to peptide vendors. We do not accept payment from drug manufacturers or telehealth clinics. Commissions never influence editorial rankings.
Category referenceReference pick

BD Ultra-Fine Nano 31G × 5/16" (8 mm) insulin syringe

The 31 G × 5/16" specification is the default described in Frid et al. 2016 (Mayo Clinic Proceedings) for subcutaneous administration in most adults. BD is the manufacturer most frequently referenced in US nursing-education literature.

The ranked list

Referenced across the literature, in order.

5 references
  1. 01
    Category reference

    BD Ultra-Fine Nano 31G × 5/16" (8 mm)

    A widely referenced U-100 insulin syringe specification in the subcutaneous-injection technique literature. Luer-integrated needle; single-use.

  2. 02
    Budget reference

    Easy Touch 31G × 5/16" (8 mm)

    Common secondary specification cited in patient-education references. Same gauge and length convention as the BD reference product.

  3. 03
    Clinical reference

    Covidien Monoject 31G × 5/16"

    Hospital-brand U-100 insulin syringe carried by medical-supply distributors. Referenced in clinical-supply catalogues.

  4. 04
    Longer-length reference

    BD SafetyGlide 30G × 1/2" (12.7 mm)

    Cited in the technique literature for cases where the 5/16" specification does not reach subcutaneous tissue (for example, individuals with substantial adipose in a given site).

  5. 05
    Pen-device reference

    NovoFine Plus 32G × 4 mm (pen needle)

    A common pen-needle specification paired with Novo Nordisk pen devices as referenced in the Ozempic and Wegovy Instructions for Use.

Methodology

How this reference was written

The technique we verified
We verified each step against the relevant manufacturer Instructions for Use, Frid et al. 2016 (Mayo Clinic Proceedings), and the CDC injection-safety guidance. Where sources disagreed, we defaulted to the most conservative and noted the discrepancy.
The sources we triangulated
Peer-reviewed injection-technique literature, manufacturer package inserts, USP monographs, CDC and WHO published standards, and FDA labelling. Links and DOIs in the Sources section below. Unsourced claims are not published.
The failure modes we tested
We document known-wrong outcomes for the common mistakes, partial dose delivery, injection-site bruising, pen misuse, reconstitution error, and describe what the published literature says to do when they happen. The red-box call-outs are drawn from these failure modes.
What we're still verifying
Pen manufacturer Instructions for Use change. FDA labelling gets updated. A named credentialed reviewer (RN, NP, or PharmD) is joining the masthead by month 6. Until then, verify every technique decision with your own prescriber and the package insert that came with your medication.
FAQ

What the literature answers next.

What gauge does the published technique literature describe as standard?
Frid et al. 2016 (Mayo Clinic Proceedings) describes 4–6 mm pen needles and 31 G × 5/16" (8 mm) U-100 syringes as appropriate for most adults receiving subcutaneous injection. The same reference describes 32 G × 4 mm as equivalent in efficacy with reduced insertion-force perception.
Is higher gauge number thinner or thicker?
A higher gauge number corresponds to a thinner needle. 31 G is thinner than 30 G, which is thinner than 29 G. The needle-diameter values are defined by the Birmingham Wire Gauge scale referenced in ISO 7864.
When does the literature describe using a longer needle?
Longer needles (for example, 1/2" / 12.7 mm) are described in the technique literature for individuals in whom the standard 5/16" length may not consistently reach subcutaneous tissue at a chosen site. Frid et al. 2016 discuss this scenario with reference to BMI and site selection.
Is needle reuse described as acceptable?
No. The CDC injection-safety guidance and the published injection-technique literature describe single-use needles only. Reuse has been associated with needle-tip dulling, site trauma, and lipohypertrophy risk.
Are pen needles and insulin-syringe needles interchangeable?
No. Pen needles are designed to thread onto the cartridge seal of specific pen devices and are double-ended. Insulin-syringe needles are integrated with the barrel of a U-100 syringe. The two formats are not interchangeable.
What disposal method is described?
An FDA-cleared sharps container is described in CDC injection-safety guidance and in most state-level household sharps-disposal regulations. Recapping is not described in any published safety guidance.
What would revise this page

A new manufacturer Instructions-for-Use revision. A peer-reviewed injection-technique paper that reports a different outcome. An FDA label update. A change to USP chapter guidance. We revise this page within a week of the cited source changing and mark what changed at the bottom.

The editorial team

About The InjectCompass Editorial Team

The InjectCompass Editorial Team is a small group of writers working from published nursing-education literature, manufacturer package inserts, and peer-reviewed injection-technique research. Our content is reviewed against published best practice before publication. We are adding a named credentialed reviewer (RN, NP, or PharmD) to the masthead; until then, readers should verify all guidance with their own prescriber and the manufacturer package insert that came with their medication. If you spot an error, write to corrections@injectcompass.com, we want to know.

Related posts

The Dispatch

Your First Injection, a one-page cheat sheet.

A printable, step-numbered PDF covering supplies, technique, site rotation, and the three questions to ask your prescriber. Free.

By subscribing, you agree to our Privacy Policy. One practical email per week. Unsubscribe anytime.